D-AP5 (CAS: 79055-68-8)
|
SKU-Pack Size | Availability | Size | Price | |
EBC51083-1ML | In Stock | 1mL(10mM in Water) | £152.90 | |
EBC51083-5MG | In Stock | 5mg | £119.90 | |
EBC51083-10MG | In Stock | 10mg | £174.90 | |
EBC51083-50MG | In Stock | 50mg | £713.90 |
Please Select The Country You Are In To Find Your Local Distributor. |
CUlabSciences | Phone:+44 (0) 1232 330008 | |
Cambridge House St Thomas' Place Ely, | E-mail:sales@culabsciences.co.uk | |
United Kingdom | Cambridge CB27 9RD UK | Web:www.culabsciences.co.uk |
Product Information | |||||||||||||||||||||
Synonym(s) | 2-APV, 5 Phosphononorvaline | ||||||||||||||||||||
Chemical Name | D-(-)-2-Amino-5-phosphonopentanoic acid | ||||||||||||||||||||
Application | D-AP5 is a selective antagonist of the NMDA receptor | ||||||||||||||||||||
CAS Number | 79055-68-8 | ||||||||||||||||||||
Purity | ≥99.0% | ||||||||||||||||||||
Molecular Weight | 197.13 | ||||||||||||||||||||
Molecular Formula | C₅H₁₂NO₅P | ||||||||||||||||||||
SMILES | C(CC(C(=O)O)N)CP(=O)(O)O | ||||||||||||||||||||
Target & IC50 | Glutamate NMDA receptor: IC50 = 0.88 μM (Rattus norvegicus) | ||||||||||||||||||||
Solubility | H2O : 27.78 mg/mL (140.92 mM) | ||||||||||||||||||||
Preparing Stock Solutions |
|
||||||||||||||||||||
Shipping | Gel Pack | ||||||||||||||||||||
Storage | Store at -20°C | ||||||||||||||||||||
Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |
Product Description | |
D-AP5 is a selective antagonist of the NMDA receptor. D(−)-2-Amino-5-phosphonovaleric acid is described to antagonize amino acid-induced synaptic excitations, blocking L-aspartate and dorsal root-evoked spinal neuron excitation, without affecting cholinergic excitation induced by exogenous acetylcholine administration. Evoked electrical activity of neurons is suppressed by D(−)-2-Amino-5-phosphonovaleric acid antagonism of motoneuronal depolarizations at the NMDAR. The (+)-stereoisomer of D(−)-2-Amino-5-phosphonovaleric acid demonstrates considerably diminished NMDAR activity as compared to this (−)-isomer. |
Specific Protocols | |